Accéder au contenu
Merck

Mechanical preconditioning enables electrophysiologic coupling of skeletal myoblast cells to myocardium.

The Journal of thoracic and cardiovascular surgery (2012-09-18)
Klaus Neef, Yeong-Hoon Choi, Sureshkumar Perumal Srinivasan, Philipp Treskes, Douglas B Cowan, Christof Stamm, Martin Rubach, Roland Adelmann, Thorsten Wittwer, Thorsten Wahlers
RÉSUMÉ

The effect of mechanical preconditioning on skeletal myoblasts in engineered tissue constructs was investigated to resolve issues associated with conduction block between skeletal myoblast cells and cardiomyocytes. Murine skeletal myoblasts were used to generate engineered tissue constructs with or without application of mechanical strain. After in vitro myotube formation, engineered tissue constructs were co-cultured for 6 days with viable embryonic heart slices. With the use of sharp electrodes, electrical coupling between engineered tissue constructs and embryonic heart slices was assessed in the presence or absence of pharmacologic agents. The isolation and expansion procedure for skeletal myoblasts resulted in high yields of homogeneously desmin-positive (97.1% ± 0.1%) cells. Mechanical strain was exerted on myotubes within engineered tissue constructs during gelation of the matrix, generating preconditioned engineered tissue constructs. Electrical coupling between preconditioned engineered tissue constructs and embryonic heart slices was observed; however, no coupling was apparent when engineered tissue constructs were not subjected to mechanical strain. Coupling of cells from engineered tissue constructs to cells in embryonic heart slices showed slower conduction velocities than myocardial cells with the embryonic heart slices (preconditioned engineered tissue constructs vs embryonic heart slices: 0.04 ± 0.02 ms vs 0.10 ± 0.05 ms, P = .011), lower maximum stimulation frequencies (preconditioned engineered tissue constructs vs embryonic heart slices: 4.82 ± 1.42 Hz vs 10.58 ± 1.56 Hz; P = .0009), and higher sensitivities to the gap junction inhibitor (preconditioned engineered tissue constructs vs embryonic heart slices: 0.22 ± 0.07 mmol/L vs 0.93 ± 0.15 mmol/L; P = .0004). We have generated skeletal myoblast-based transplantable grafts that electrically couple to myocardium.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
1-Heptanol, 98%
Sigma-Aldrich
1-Heptanol, ≥99.5% (GC)
Sigma-Aldrich
1-Heptanol, ≥97%, FCC, FG
Supelco
1-Heptanol, analytical standard, ≥99.5% (GC)